Health Status and the Need for Social Return of Drug Abusers in Guangdong Province

November 9, 2023 updated by: Wei XIA, PhD, Sun Yat-sen University

Health Status and the Need for Social Return of Drug Abusers in Guangdong Province: a Secondary Data Analysis Study

This study intends to conduct a secondary analysis of the data from the investigation on the status quo of anti-drug rehabilitation work and management needs in Guangdong Province.

Study Overview

Detailed Description

The drug problem is a major problem that threatens individuals' physical and mental health, family happiness, national security, regional stability and world peace. In recent years, anti-drug departments in various regions of Guangdong Province have adhered to the arrangement and deployment of the National Anti-Drug Office, the provincial Party committee and the provincial government and the Party committee of the Public Security Department, focused on preventing the harm of synthetic drugs, improved the system, implemented responsibilities, and innovated methods, and constantly improved the anti-drug and drug rehabilitation work in Guangdong.

Nowadays, with the improvement of the level of social and economic development, the personnel structure and characteristics of drug abusers in Guangdong Province have undergone corresponding changes, and the effect of the existing control policies on drug abusers has also shown a weak stage, which needs to be adjusted and updated in time.

In this context, Guangdong Provincial Public Security Department has carried out research on anti-drug management countermeasures, and actively discussed the status quo, difficulties and reform direction of anti-drug management in the new era.

This study intends to conduct a secondary analysis based on the data obtained from the investigation and research on the status quo of drug control and detoxification work and management needs in Guangdong Province, aiming to describe the demographic and sociological characteristics of drug abusers in Guangdong Province, as well as their psychosocial experience of receiving interpretation intervention and the status quo of social regression needs. What's more, this study also devoted to forming a practical multi-department co-management model of community comprehensive management of drug addicts in Guangdong Province in the new era, to comprehensively improve the management level of drug abusers in Guangdong Province, serving grassroots communities, and build a harmonious society.

Study Type

Observational

Enrollment (Estimated)

7106

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510080
        • Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Drug abusers who registered in any of a streets or townships of Guangdong Province would be selected.

Description

Inclusion Criteria:

  • Cities in Guangdong Province are selected according to the geographical distribution, development level, economic level and population distribution of the cities.
  • Drug abusers who registered in any of a streets or townships of Guangdong Province would be selected.
  • Drug abusers who have abstained for more than 3 years.
  • All age groups under 30 years old, between 30 and 50 years old and over 50 years old were covered.

Exclusion Criteria:

  • Eliminate more than 20 questions missed or not answered questionnaires.
  • The questionnaires which be filled out by the same respondent repeatedly.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Drug abusers

Drug abusers who registered in any of the 80 streets and 40 towns selected according to the economic level and population distribution of each city and other reference standards have been included in the study. A total of 6906 valid questionnaires have been collected.

The interviewees were selected from 5000 participants in the quantitative questionnaire. Priority is given to drug users who have abstained for more than three years, and all age groups under 30 years old, between 30 and 50 years old and over 50 years old are covered.

The investigators have made an electronic questionnaire through the questionnaire star, and send the link or two-dimensional code of the electronic questionnaire to the subjects through WeChat or SMS to remind them to fill in the answer on the mobile phone or computer.

The questionnaire consisted of four parts: (1) basic information of the interviewees, (2) drug abuse of the interviewees, (3) drug treatment interventions received by the interviewees, and (4) problems encountered by the interviewees when they return to society.

The in-depth personal interview was conducted in a semi-structured way. The outline of the interview was formulated from seven aspects: drug use history, drug abstinence history, relapse situation, living conditions, physical and mental health status, return to society status, and active drug abstinence willingness of the drug abstinence personnel. The aim was to understand the needs of drug addicts in terms of family relationship, peer relationship, history of drug use, history of drug withdrawal, employment, economy, social support network, psychology, and assistance.
Drug rehabilitation institutions
The drug rehabilitation institutions included social work organization, compulsory detoxification center and rehabilitation center, which were selected according to the specific conditions of the selected cities, and the final number of participants was determined according to the personnel Settings of these institutions.

The colloquia were carried out in the form of group interviews, 1-2 people from each different institution were selected to participate, and the number of people in each colloquium was controlled to be between 6 and 12.

The colloquia mainly focused on: ① The status quo of the implementation of the local drug drug treatment policy, ② the status quo of the compulsory isolation drug treatment work, ③ the status quo of the work of social workers for drug drug treatment, ④ the status quo of the work of community health centers, ⑤ the operation of various mechanisms in the work of various units, and ⑥ what content in the drug control work needs assistance from other departments and what external resources are needed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health status
Time Frame: Baseline
The main indicator of health status is the Brief Symptom Inventory-18 (BSI-18) scale, a simplified version of the commonly used psychological evaluation scale SCL-90, consisting of 18 items that are answered on a Likert scale of 0 to 4 points. A higher total score on the BSI-18 indicates a higher level of psychological distress for the respondent.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socio-demographic information of drug abusers
Time Frame: Baseline
The socio-demographic data collected through the structural questionnaire includes gender, age, education level, income, family size and health status of drug abusers.
Baseline
Withdrawal symptoms
Time Frame: Baseline
The symptoms that the participants experienced during they quit the drugs. A checklist including 18 symptoms was used the measure the withdrawal symptoms with a Likert scale of 1 to 5 points. A higher score indicates more serious the participants experienced certain withdrawal symptoms.
Baseline
Addiction treatment
Time Frame: Baseline
The treatment that the participants ever received. A checklist including 4 common treatments used with a Likert scale of 0 to 4 points. A higher score indicates more effective in treating the drug abuse.
Baseline
Barriers and support on returning to social
Time Frame: Baseline
The barriers and support that the participants experienced when they tried to return to social. A checklist including 8 common barriers and 5 common support with a Likert scale of 1 to 4 points. A higher score indicates more serious or more necessary to the participants.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wei Xia, PhD, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2023

Primary Completion (Estimated)

July 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

October 13, 2023

First Submitted That Met QC Criteria

November 9, 2023

First Posted (Actual)

November 15, 2023

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 9, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • WXIA-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The non-identified individual participant data will be shared after the outcomes have been published.

IPD Sharing Time Frame

After the publication of the study

IPD Sharing Access Criteria

Researchers should contact the PI for approval of the study protocol.

IPD Sharing Supporting Information Type

  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Use

Clinical Trials on Online questionnaire survey

Subscribe